JENNIFER RICHARDSON: Open Payments
NPI 1669529392 · PEABODY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,893 in 73 payments from 26 companies in 2025. Trend: 2023 $840 · 2024 $1,392 · 2025 $1,893
Food & beverage: $1,893
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 15 | $372 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $239 |
| HARMONY BIOSCIENCES LLC | 3 | $227 |
| ABBVIE INC. | 9 | $193 |
| Lilly USA, LLC | 6 | $158 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Boston Scientific Corporation | 2 | $74 |
| PFIZER INC. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Inspire Medical Systems, Inc. | 2 | $44 |
Products named: REXULTI, CAPLYTA, WAKIX, VRAYLAR, JARDIANCE, MOUNJARO, General - Therapies, UBRELVY.
Industry payments across MA — which companies pay providers there.
